EUVIMEDEUVIMED entdecken
Crossref

Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion

Di Gao, Dan Zhu, Xue Zhou, Shuai Dong, Yuejie Chen iD

Molecular Pharmaceutics · 02.01.2023 · 20 (1) · 409-418

DOI: 10.1021/acs.molpharmaceut.2c00695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 19.12.2022. Verfasst von Di Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Minzu University of China, 100081 Beijing, China. Hauptthemen laut MEDLINE: Felodipine, Polymers. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Central University Basic Research Fund of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhomogeneity is a key factor that significantly influences the dissolution behavior of amorphous solid dispersion (ASD). However, the underlying mechanisms of the effects of inhomogeneous phase on the dissolution characteristics as well as the bioavailability of ASDs are still unclear. In this study, two types of felodipine/PVPVA based ASDs with 30 wt % drug loading but different homogeneity were prepared: homogeneous "30 wt % ASD" prepared by spray drying, as well as inhomogeneous "30 wt % PM" prepared by physically mixing the sprayed dried 70 wt % ASD with PVPVA. We aimed to investigate (1) drug-polymer interaction mechanism and "apparent" interaction strength within the two ASDs and (2) dissolution mechanism as well as in vivo performance of the two ASDs. DSC thermogram revealing a single Tg in 30 wt % ASD confirmed its homogeneous phase. 1H NMR, FT-IR, and DVS studies collectively proved that strong hydrogen bonding interactions formed between felodipine and PVPVA in ASDs. Moreover, homogeneous "30 wt % ASD" has more numbers of interacting drug-polymer pairs, and thus exhibits stronger "apparent" interaction strength comparing with that of inhomogeneous "30 wt % PM". Unexpectedly,in the in vitro dissolution studies, inhomogeneous "30 wt % PM" showed much faster dissolution and also generated drug concentration ∼4.4 times higher than that of homogeneous "30 wt % ASD". However, drug precipitate recrystallized much slower in homogeneous "30 wt % ASD", presumably because much more polymer coprecipitated with amorphous drug in this system, which helps inhibiting drug crystallization. Surprisingly, homogeneous "30 wt % ASD" showed a significantly higher bioavailability in the in vivo pharmacokinetic studies, with the maximum plasma concentrations (Cmax) and the area under the curve (AUC) values of about 2.7 and 2.3 times higher than those of inhomogeneous "30 wt % PM". The above findings indicated that the amorphous state of drug precipitate contributes significantly to increase bioavailability of ASDs, while traditional in vitro dissolution studies, for instance, if we only compare the dissolved drug in solution or the capability of an ASD to generate supersaturation, are inadequate to predict in vivo performance of ASDs. In conclusion, the phase behavior of ASDs directly impact the formation of drug-polymer interaction, which controls not only drug supersaturation in solution but also drug crystallization in precipitate, and ultimately affect the in vivo performance of ASDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FelodipinePolymersSolubilityBiological AvailabilitySpectroscopy, Fourier Transform InfraredDrug Liberation

Stichwörter der Autor:innen

amorphous solid dispersion (ASD)bioavailabilitycrystallizationdrug−polymer interactioninhomogeneous phasesupersaturation

Substanzen

FelodipinePolymers

Autor:innen und Institutionen

  • School of Pharmacy, Minzu University of China, 100081 Beijing, China.
  • Chengdu Institute of Biology, Chinese Academy of Sciences, 610000 Chengdu, China.
  • Key Laboratory of Mass Spectrometry Imaging and Metabolomics (Minzu University of China), State Ethnic Affairs Commission, 100081 Beijing, China.

ORCID-Profile: Yuejie Chen

Förderung

  • Central University Basic Research Fund of China
  • National Natural Science Foundation of China

Zitieren

APA

Gao, D., Zhu, D., Zhou, X., Dong, S., & Chen, Y. (2023). Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion. Molecular Pharmaceutics, 20(1), 409-418. https://doi.org/10.1021/acs.molpharmaceut.2c00695

Vancouver

Gao D, Zhu D, Zhou X, Dong S, Chen Y. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion. Molecular Pharmaceutics. 2023;20(1):409-418. doi:10.1021/acs.molpharmaceut.2c00695

BibTeX
@article{Gao2023,
  author = {Gao, Di and Zhu, Dan and Zhou, Xue and Dong, Shuai and Chen, Yuejie},
  title = {Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion},
  journal = {Molecular Pharmaceutics},
  year = {2023},
  volume = {20},
  number = {1},
  pages = {409--418},
  doi = {10.1021/acs.molpharmaceut.2c00695}
}
Kostenlos starten →